Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors-Reference-Cited by-同舟云学术

Risk Factors for Targeted Fungal and Mycobacterial Infections in Patients Taking Tumor Necrosis Factor Inhibitors

Published:2016-02-24 Issue:3 Volume:68 Page:597-603
ISSN:2326-5191
Container-title:Arthritis & Rheumatology
language:en
Short-container-title:Arthritis & Rheumatology

Author:

Salt Elizabeth¹,Wiggins Amanda T.¹,Rayens Mary Kay¹,Huaman Moises A.¹,Mannino David¹,Schwieterman Philip¹,Merkley Scott A.²,Jones Allison R.¹,Crofford Leslie J.³

Affiliation:

1. University of Kentucky; Lexington

2. Lexington Clinic; Lexington Kentucky

3. Vanderbilt University; Nashville Tennessee

Funder

National Center for Research Resources (NCRR)

National Center for Advancing Translational Sciences

NIH

Clinical and Translational Science Award Consortium

NCRR

Publisher

Wiley

Subject

Immunology,Rheumatology,Immunology and Allergy

Reference15 articles.

1. American College of Rheumatology 2012 https://www.rheumatology.org/Practice/Clinical/Patients/Medications/Anti-TNF/

2. Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonists;Chirch;J Am Acad Dermatol,2014

3. Centers for Disease Control and Prevention 2014 http://www.cdc.gov/tb/statistics/default.htm

4. Optimizing screening for tuberculosis and hepatitis B prior to starting tumor necrosis factor-α inhibitors in Crohn's disease;Have;Dig Dis Sci,2014

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Infections in the era of immunobiologicals;Anais Brasileiros de Dermatologia;2024-03

2. Incidence of histoplasmosis in patients receiving TNF-alpha inhibitors: A systematic review and meta-analysis;Medicine;2023-12-08

3. Association of Tumor Necrosis Factor Inhibitors with the Risk of Nontuberculous Mycobacterial Infection in Patients with Rheumatoid Arthritis: A Nationwide Cohort Study;Journal of Clinical Medicine;2023-11-09

4. Infections fongiques au cours des thérapeutiques ciblées et immunothérapies;La Revue de Médecine Interne;2023-06

5. Review article: latent tuberculosis in patients with inflammatory bowel diseases receiving immunosuppression—risks, screening, diagnosis and management;Alimentary Pharmacology & Therapeutics;2022-05-20